199 related articles for article (PubMed ID: 19157801)
21. [Drug screening model acting on out-membrane protein OprM in pseudomonas aeruginosa efflux pump system].
Tian R; Yu LY; Xiao CL; Zuo L; Yao TJ; Yang LX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):359-63. PubMed ID: 15379256
[TBL] [Abstract][Full Text] [Related]
22. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
[TBL] [Abstract][Full Text] [Related]
23. Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Vettoretti L; Plésiat P; Muller C; El Garch F; Phan G; Attrée I; Ducruix A; Llanes C
Antimicrob Agents Chemother; 2009 May; 53(5):1987-97. PubMed ID: 19258280
[TBL] [Abstract][Full Text] [Related]
24. Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
Ludwig E; Konkoly-Thege M; Kuti JL; Nicolau DP
Int J Antimicrob Agents; 2006 Nov; 28(5):433-8. PubMed ID: 17046212
[TBL] [Abstract][Full Text] [Related]
25. Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
Sugimura M; Maseda H; Hanaki H; Nakae T
Antimicrob Agents Chemother; 2008 Nov; 52(11):4141-4. PubMed ID: 18676884
[TBL] [Abstract][Full Text] [Related]
26. Measurement of Pseudomonas aeruginosa multidrug efflux pumps by quantitative real-time polymerase chain reaction.
Yoneda K; Chikumi H; Murata T; Gotoh N; Yamamoto H; Fujiwara H; Nishino T; Shimizu E
FEMS Microbiol Lett; 2005 Feb; 243(1):125-31. PubMed ID: 15668010
[TBL] [Abstract][Full Text] [Related]
27. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
Rieg S; Huth A; Kalbacher H; Kern WV
Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
[TBL] [Abstract][Full Text] [Related]
28. [Low-level resistance to fluoroquinolones conferred by efflux overproduction in Pseudomonas aeruginosa: clinical significance and routine detection].
Hocquet D; Patry I; Dupont P; Bize M; Jeannot K; Chavanet P; Plésiat P
Pathol Biol (Paris); 2005; 53(8-9):495-9. PubMed ID: 16203109
[TBL] [Abstract][Full Text] [Related]
29. Fuzheng Touxie Jiedu Huayu Decoction inhibits the MexAB-OprM efflux pump and quorum sensing-mediated biofilm formation in difficult-to-treat multidrug resistance Pseudomonas aeruginosa.
Liu T; Xu H; Huang T; Liu G; Cao H; Lin Y; Li Y; Li Y; Yao X
J Ethnopharmacol; 2024 Oct; 332():118365. PubMed ID: 38796070
[TBL] [Abstract][Full Text] [Related]
30. Resistance to beta-lactam antibiotics in Pseudomonas aeruginosa due to interplay between the MexAB-OprM efflux pump and beta-lactamase.
Nakae T; Nakajima A; Ono T; Saito K; Yoneyama H
Antimicrob Agents Chemother; 1999 May; 43(5):1301-3. PubMed ID: 10223959
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study.
Cavallo JD; Hocquet D; Plesiat P; Fabre R; Roussel-Delvallez M;
J Antimicrob Chemother; 2007 May; 59(5):1021-4. PubMed ID: 17412726
[TBL] [Abstract][Full Text] [Related]
32. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate.
Yoshida K; Nakayama K; Ohtsuka M; Kuru N; Yokomizo Y; Sakamoto A; Takemura M; Hoshino K; Kanda H; Nitanai H; Namba K; Yoshida K; Imamura Y; Zhang JZ; Lee VJ; Watkins WJ
Bioorg Med Chem; 2007 Nov; 15(22):7087-97. PubMed ID: 17869116
[TBL] [Abstract][Full Text] [Related]
33. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability.
Buyck JM; Plésiat P; Traore H; Vanderbist F; Tulkens PM; Van Bambeke F
Clin Infect Dis; 2012 Aug; 55(4):534-42. PubMed ID: 22573850
[TBL] [Abstract][Full Text] [Related]
34. Expression of MexAB-OprM efflux pump system and susceptibility to antibiotics of different Pseudomonas aeruginosa clones isolated from patients hospitalized in two intensive care units at University Hospital in Bialystok (northeastern Poland) between January 2002 and December 2009.
Sacha P; Wieczorek P; Ojdana D; Hauschild T; Milewski R; Czaban S; Poniatowski B; Tryniszewska E
APMIS; 2014 Oct; 122(10):931-40. PubMed ID: 24628702
[TBL] [Abstract][Full Text] [Related]
35. Directed evolution of a bacterial efflux pump: adaptation of the E. coli TolC exit duct to the Pseudomonas MexAB translocase.
Bokma E; Koronakis E; Lobedanz S; Hughes C; Koronakis V
FEBS Lett; 2006 Oct; 580(22):5339-43. PubMed ID: 16979625
[TBL] [Abstract][Full Text] [Related]
36. [Two efflux systems expressed simultaneously in clinical Pseudomonas aeruginosa].
Hocquet D; Llanes C; Patry I; El Garch F; Plésiat P
Pathol Biol (Paris); 2004 Oct; 52(8):455-61. PubMed ID: 15465264
[TBL] [Abstract][Full Text] [Related]
37. In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycin.
Martha B; Croisier D; Durand D; Hocquet D; Plesiat P; Piroth L; Portier H; Chavanet P
Clin Microbiol Infect; 2006 May; 12(5):426-32. PubMed ID: 16643518
[TBL] [Abstract][Full Text] [Related]
38. A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa.
Li Y; Mima T; Komori Y; Morita Y; Kuroda T; Mizushima T; Tsuchiya T
J Antimicrob Chemother; 2003 Oct; 52(4):572-5. PubMed ID: 12951344
[TBL] [Abstract][Full Text] [Related]
39. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions.
Schweizer HP
Genet Mol Res; 2003 Mar; 2(1):48-62. PubMed ID: 12917802
[TBL] [Abstract][Full Text] [Related]
40. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes.
Pamp SJ; Gjermansen M; Johansen HK; Tolker-Nielsen T
Mol Microbiol; 2008 Apr; 68(1):223-40. PubMed ID: 18312276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
